ATRC AtriCure, Inc.

NASDAQ
$55.39

AtriCure, Inc. (ATRC) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bearish Selling ran elevated versus ATRC's own trailing one-year pace, with 79% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 4 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
2
2 transactions
Purchases
$0
0 shares
Sales
$689.7K
10,856 shares
Net activity
-$689.7K
purchases less sales

How much of that selling was preplanned? 79% planned / 21% discretionary

10b5-1 plan sales $546.3K 1 transaction · 8,404 shares
Discretionary sales $143.4K 1 transaction · 2,452 shares

Largest single sale: $546.3K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
JOHNSON B KRISTINE Director Sell 2,452 $58.48 $143.4K 53,502 −4.4% of holding
Privitera Salvatore Chief Technical Officer Sell 10b5-1 8,404 $65.00 $546.3K 134,341 −5.9% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.